Literature DB >> 17981570

The type II transmembrane serine protease matriptase-2--identification, structural features, enzymology, expression pattern and potential roles.

Andrew J Ramsay1, Janet C Reid, Gloria Velasco, James P Quigley, John D Hooper.   

Abstract

Matriptase-2 (also known as TMPRSS6) is a recently identified member of the type II transmembrane serine protease (TTSP) family. Structurally this enzyme contains a short cytoplasmic amino terminal tail, a transmembrane region, a stem region containing two CUB domains and three LDL receptor class A domains, and at the carboxy terminal a trypsin-like serine protease domain. The matriptase-2 gene and encoded protein are highly conserved in mammals. Biochemically matriptase-2 has substrate specificity similar to the structurally related protein matriptase (also known as MT-SP1). Although the patho-physiological functions of matriptase-2 are not known, its high mRNA expression in liver and several cancers indicate that this enzyme, similar to other TTSPs, will likely have important cell surface associated roles in normal and disease states. Here we overview the identification of matriptase-2, summarise its structural features, biochemistry, expression pattern and disease associations and discuss its potential functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981570     DOI: 10.2741/2702

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  14 in total

Review 1.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

Review 2.  Anchoring junctions as drug targets: role in contraceptive development.

Authors:  Dolores D Mruk; Bruno Silvestrini; C Yan Cheng
Journal:  Pharmacol Rev       Date:  2008-05-15       Impact factor: 25.468

3.  Efficient and wash-free labeling of membrane proteins using engineered Npu DnaE split-inteins.

Authors:  Euiyeon Lee; Kyoungmi Min; Young-Tae Chang; Youngeun Kwon
Journal:  Protein Sci       Date:  2018-09-24       Impact factor: 6.725

4.  Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality.

Authors:  François Béliveau; Cédric Brulé; Antoine Désilets; Brandon Zimmerman; Stéphane A Laporte; Christine L Lavoie; Richard Leduc
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

5.  N-glycosylation is required for matriptase-2 autoactivation and ectodomain shedding.

Authors:  Jiang Jiang; Jianfeng Yang; Ping Feng; Bin Zuo; Ningzheng Dong; Qingyu Wu; Yang He
Journal:  J Biol Chem       Date:  2014-05-27       Impact factor: 5.157

Review 6.  Serine proteases.

Authors:  Enrico Di Cera
Journal:  IUBMB Life       Date:  2009-05       Impact factor: 3.885

7.  A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA.

Authors:  Sandro Altamura; Flavia D'Alessio; Barbara Selle; Martina U Muckenthaler
Journal:  Biochem J       Date:  2010-11-01       Impact factor: 3.857

Review 8.  Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis.

Authors:  Andrew J Ramsay; John D Hooper; Alicia R Folgueras; Gloria Velasco; Carlos López-Otín
Journal:  Haematologica       Date:  2009-04-18       Impact factor: 9.941

9.  Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels.

Authors:  John C Chambers; Weihua Zhang; Yun Li; Joban Sehmi; Mark N Wass; Delilah Zabaneh; Clive Hoggart; Henry Bayele; Mark I McCarthy; Leena Peltonen; Nelson B Freimer; Surjit K Srai; Patrick H Maxwell; Michael J E Sternberg; Aimo Ruokonen; Gonçalo Abecasis; Marjo-Riitta Jarvelin; James Scott; Paul Elliott; Jaspal S Kooner
Journal:  Nat Genet       Date:  2009-10-11       Impact factor: 38.330

10.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.

Authors:  Laura Silvestri; Alessia Pagani; Antonella Nai; Ivana De Domenico; Jerry Kaplan; Clara Camaschella
Journal:  Cell Metab       Date:  2008-10-30       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.